| Social media and rating sites as tools to understanding quality of care: a scoping review LM Verhoef, TH Van de Belt, LJ Engelen, L Schoonhoven, RB Kool Journal of medical Internet research 16 (2), e56, 2014 | 157 | 2014 |
| Down‐titration and discontinuation strategies of tumour necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity LM Verhoef, BJF Van Den Bemt, A Van Der Maas, JE Vriezekolk, ... Cochrane Database of Systematic Reviews, 2019 | 84 | 2019 |
| The disciplined healthcare professional: a qualitative interview study on the impact of the disciplinary process and imposed measures in the Netherlands LM Verhoef, JW Weenink, S Winters, PBM Robben, GP Westert, RB Kool BMJ open 5 (11), e009275, 2015 | 57 | 2015 |
| Is the role as gatekeeper still feasible? A survey among Dutch general practitioners JJG Wammes, PPT Jeurissen, LM Verhoef, WJJ Assendelft, GP Westert, ... Family practice 31 (5), 538-544, 2014 | 57 | 2014 |
| bDMARD dose reduction in rheumatoid arthritis: a narrative review with systematic literature search LM Verhoef, L Tweehuysen, ME Hulscher, B Fautrel, AA Den Broeder Rheumatology and Therapy 4, 1-24, 2017 | 50 | 2017 |
| Using patient experiences on Dutch social media to supervise health care services: exploratory study TH van de Belt, LJ Engelen, LM Verhoef, MJA van der Weide, ... Journal of medical Internet research 17 (1), e7, 2015 | 45 | 2015 |
| Dose tapering of biologics in patients with psoriasis: a scoping review CAJ Michielsens, ME Van Muijen, LM Verhoef, J van den Reek, ... Drugs 81, 349-366, 2021 | 31 | 2021 |
| The patient perspective on biologic DMARD dose reduction in rheumatoid arthritis: a mixed methods study LM Verhoef, EMH Selten, JE Vriezekolk, AJL de Jong, ... Rheumatology 57 (11), 1947-1955, 2018 | 30 | 2018 |
| Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial LM Verhoef, N den Broeder, RM Thurlings, WH van der Laan, ... The Lancet Rheumatology 1 (3), e145-e153, 2019 | 27 | 2019 |
| Ultra-low dose of rituximab in rheumatoid arthritis: study protocol for a randomised controlled trial AA den Broeder, LM Verhoef, J Fransen, R Thurlings, BJF van den Bemt, ... Trials 18, 1-9, 2017 | 26 | 2017 |
| Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in psoriatic arthritis and axial spondyloarthritis: a randomised controlled non-inferiority trial CAJ Michielsens, N den Broeder, FHJ van den Hoogen, EAM Mahler, ... Annals of the rheumatic diseases 81 (10), 1392-1399, 2022 | 17 | 2022 |
| Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study CAJ Michielsens, N den Broeder, MLM Mulder, FHJ van den Hoogen, ... Rheumatology 61 (6), 2307-2315, 2022 | 17 | 2022 |
| Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial CAJ Michielsens, N Boers, N den Broeder, MH Wenink, A van der Maas, ... Trials 21, 1-12, 2020 | 14 | 2020 |
| Rheumatologists’ guideline adherence in rheumatoid arthritis: a randomised controlled study on electronic decision support, education and feedback N Lesuis, RF van Vollenhoven, RP Akkermans, LM Verhoef, ME Hulscher, ... Clin Exp Rheumatol 36 (1), 21-28, 2018 | 11 | 2018 |
| Drug levels, anti-drug antibodies and B-cell counts were not predictive of response in rheumatoid arthritis patients on (ultra-) low-dose rituximab MHM Wientjes, TMG Gijzen, N den Broeder, K Bloem, A de Vries, ... Rheumatology 61 (10), 3974-3980, 2022 | 8 | 2022 |
| Cost-effectiveness of five different anti-tumour necrosis factor tapering strategies in rheumatoid arthritis: a modelling study LM Verhoef, DPG Bos, CHM van den Ende, FHJ van den Hoogen, ... Scandinavian Journal of Rheumatology 48 (6), 439-447, 2019 | 8 | 2019 |
| Rituximab dose-dependent infection risk in rheumatoid arthritis is not mediated through circulating immunoglobulins, neutrophils or B cells MAA Opdam, JH de Leijer, N den Broeder, RM Thurlings, ... Rheumatology 62 (1), 330-334, 2023 | 7 | 2023 |
| Implementation of protocolized tight control and biological dose optimization in daily clinical practice: results of a pilot study N Lesuis, LM Verhoef, LM Nieboer, GA Bruyn, P Baudoin, ... Scandinavian Journal of Rheumatology 46 (2), 152-155, 2017 | 7 | 2017 |
| Onnodige zorg in de Nederlandse gezondheidszorg, gezien vanuit het perspectief van de huisarts J Wammes, L Verhoef, G Westert, P Assendelft, P Jeurissen, M Faber Nijmegen: Celsus, 2013 | 7 | 2013 |
| Points to consider for cost-effective use of biological and targeted synthetic DMARDs in inflammatory rheumatic diseases: results from an umbrella review and international … CJT van der Togt, B Van den Bemt, D Aletaha, R Alten, K Chatzidionysiou, ... RMD open 9 (1), e002898, 2023 | 6 | 2023 |
